Azolol Stanozolol 5 mg

• Brand: The British Dispensary Co. LTD
• Category: Oral AAS Research Compound
• Content: 400 tablets | 5 mg per tablet (2,000 mg total)
• Manufactured in: Thailand

Product Overview

Stanozolol 5 mg, sold under the research label AZOLOL, is a synthetic anabolic– androgenic steroid (AAS)

derived from dihydrotestosterone (DHT). Its 17--alkylated design allows stable oral absorption and makes it

a preferred reference standard for exploring androgen receptor (AR) modulation, lean-mass biology,

and hepatic metabolism associated with oral anabolic steroids.

Historically known as Winstrol, stanozolol provides a robust anabolic signal with relatively mild androgenic activity.

It is widely incorporated into studies focusing on selective anabolic activation, non-aromatizing steroid pathways,

and toxicology models related to liver enzyme induction and hepatocellular stress.

Key Research Highlights

Anabolic signal amplification:

Increases protein synthesis and anabolic gene transcription through AR agonism.

Lean-tissue modeling:

Commonly used in studies involving fat-free mass, metabolic efficiency, and performance-related tissue adaptations.

Hepatic metabolism marker:

As a 17--alkylated steroid, stanozolol is frequently used to investigate cholestatic patterns, enzyme elevation,

and liver-injury signaling mechanisms.

Comparative mechanistic studies:

Benchmarked against oxandrolone, methandienone, and similar AAS to evaluate differential anabolic/androgenic ratios.

Suggested Laboratory Applications

• Androgen receptor–mediated transcription and protein synthesis modeling
• Lean-mass and performance metabolism research
• Non-aromatizing anabolic pathway analysis
• Hepatotoxicity screening for 17--alkylated oral steroids
• Comparative AAS potency and toxicity profiling

Technical Specifications

PubChem-Supported Research Insights

• Strong AR-binding affinity produces significant anabolic transcriptional activity
• Does not aromatize — supports isolated androgen pathway research
• 17--alkylation introduces hepatic stress markers useful for toxicology assays
• Demonstrates consistent oral bioavailability for pharmacokinetic modeling
• Common model compound for performance-enhancement metabolism studies

Documented Research Side Effects

• Elevations in liver enzymes; cholestatic patterns
• Altered lipid metabolism ( HDL, LDL)
• Androgenic markers: acne, hair-growth shifts, sebaceous activity
• Reproductive hormone suppression in long-term models

Handling & Compliance

For Research Use Only — Not for human or veterinary consumption.

Store sealed, below 30 °C, protected from moisture and light.

Stanozolol is listed under WADA S1 prohibited anabolic agents.

Acquisition and handling require qualified researcher compliance with applicable regulations.